If HHS' 340B rebate model pilot proceeds as planned, more than 2,700 U.S. hospitals will collectively be saddled with approximately $400 million ...
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s estimates, and HRSA should delay the program’s ...
HRSA’s 340B Rebate Pilot Program: Industry Debates, Congressional Response, and Program Implications
A new chapter in the 340B Drug Pricing Program is unfolding as the Health Resources & Services Administration (“HRSA”) ...
Stitt and other Republican governors argue that drug discounts can be used to support abortion services indirectly.
The Health Resources and Services Administration (HRSA) announced last week a $52 million investment in 54 health centers to improve access to primary care for those preparing to leave incarceration.
Johnson & Johnson must scrap a pharmaceutical rebate initiative for hospitals participating in the 340B Drug Discount Program or risk federal sanctions, the Health Resources and Services ...
The Health Resources and Services Administration’s definition of who qualifies as a patient under the 340B drug pricing program is too narrowly defined, a federal judge ruled Nov. 7. The lawsuit was ...
In a letter last week, Johnson & Johnson informed certain hospitals of a major change it plans to make in the way it gives out discounts on two drugs. The company has found itself in opposition to ...
WASHINGTON, Dec. 20-- The National Health Law Program issued the following news release: In announcing updates to the women's preventive services guidelines (https ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback